CONTENTS
Issue 80 | March 2019
In association
withWhy has the stock of pink Migraleve tablets disappeared from UK shelves?
How are researchers modifying nano-material from corn for drug delivery?
Can machine learning accelerate the diagnosis and treatment of rare diseases?
A look at the success and future of Scotland’s pharmaceutical industry
What does biotech’s biggest-ever IPO tell us about drug manufacturing?
How is DelSiTech’s technology being used to deliver thermo stable vaccines?
Can CRISPR/Cas9 deliver on its promise to transform genome therapy?